In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Kristian Wachtell; Eva Gerdts; Vittorio Palmieri; Michael H Olsen; Markku S Nieminen; Vasilios Papademetriou; Kurt Boman; Björn Dahlöf; Gerard P Aurigemma; Jens E Rokkedal; Richard B Devereux

doi:10.1097/HJH.0b013e328339f943

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

Kristian Wachtell, Eva Gerdts, Vittorio Palmieri, Michael H Olsen, Markku S Nieminen, Vasilios Papademetriou, Kurt Boman, Björn Dahlöf, Gerard P Aurigemma, Jens E Rokkedal, Richard B Devereux

Medicinsk Afdeling GLO

37 Citationer (Scopus)

Abstract

Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.

Originalsprog	Engelsk
Tidsskrift	Journal of Hypertension
Vol/bind	28
Udgave nummer	7
Sider (fra-til)	1541-6
Antal sider	6
DOI	https://doi.org/10.1097/HJH.0b013e328339f943
Status	Udgivet - 1 jul. 2010

Adgang til dokumentet

10.1097/HJH.0b013e328339f943

Fingeraftryk

Dyk ned i forskningsemnerne om 'In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Wachtell, K., Gerdts, E., Palmieri, V., Olsen, M. H., Nieminen, M. S., Papademetriou, V., Boman, K., Dahlöf, B., Aurigemma, G. P., Rokkedal, J. E., & Devereux, R. B. (2010). In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. Journal of Hypertension, 28(7), 1541-6. https://doi.org/10.1097/HJH.0b013e328339f943

In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. / Wachtell, Kristian; Gerdts, Eva; Palmieri, Vittorio et al.
I: Journal of Hypertension, Bind 28, Nr. 7, 01.07.2010, s. 1541-6.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Wachtell, K, Gerdts, E, Palmieri, V, Olsen, MH, Nieminen, MS, Papademetriou, V, Boman, K, Dahlöf, B, Aurigemma, GP, Rokkedal, JE & Devereux, RB 2010, 'In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study', Journal of Hypertension, bind 28, nr. 7, s. 1541-6. https://doi.org/10.1097/HJH.0b013e328339f943

Wachtell K, Gerdts E, Palmieri V, Olsen MH, Nieminen MS, Papademetriou V et al. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. Journal of Hypertension. 2010 jul. 1;28(7):1541-6. doi: 10.1097/HJH.0b013e328339f943

@article{e587bc56cef243ebb09952aa28d07863,

title = "In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study",

abstract = "Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.",

author = "Kristian Wachtell and Eva Gerdts and Vittorio Palmieri and Olsen, {Michael H} and Nieminen, {Markku S} and Vasilios Papademetriou and Kurt Boman and Bj{\"o}rn Dahl{\"o}f and Aurigemma, {Gerard P} and Rokkedal, {Jens E} and Devereux, {Richard B}",

year = "2010",

month = jul,

day = "1",

doi = "10.1097/HJH.0b013e328339f943",

language = "English",

volume = "28",

pages = "1541--6",

journal = "Journal of Hypertension",

issn = "1473-5598",

publisher = "Lippincott Williams & Wilkins, Ltd",

number = "7",

}

TY - JOUR

T1 - In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study

AU - Wachtell, Kristian

AU - Gerdts, Eva

AU - Palmieri, Vittorio

AU - Olsen, Michael H

AU - Nieminen, Markku S

AU - Papademetriou, Vasilios

AU - Boman, Kurt

AU - Dahlöf, Björn

AU - Aurigemma, Gerard P

AU - Rokkedal, Jens E

AU - Devereux, Richard B

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.

AB - Endocardial fractional shortening (EFS) and midwall shortening (MWS) are impaired in patients with left ventricular hypertrophy. However, it remains unknown whether improvement of left ventricular systolic function during treatment reduces cardiovascular morbidity and mortality in hypertensive patients with preserved left ventricular function.

U2 - 10.1097/HJH.0b013e328339f943

DO - 10.1097/HJH.0b013e328339f943

M3 - Journal article

C2 - 20410835

SN - 1473-5598

VL - 28

SP - 1541

EP - 1546

JO - Journal of Hypertension

JF - Journal of Hypertension

IS - 7

ER -